Morgan Joseph initiates coverage on BioMarin (Nasdaq: BMRN) with a Buy rating and $20 price target, citing ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE